Smith Group Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-42,700
| Closed | -$5.14M | – | 162 |
|
|
2024
Q1 | $5.14M | Sell |
42,700
-20,270
| -32% | -$2.44M | 0.29% | 78 |
|
|
2023
Q4 | $7.75M | Buy |
+62,970
| New | +$7.75M | 0.45% | 71 |
|
|
2020
Q2 | – | Sell |
-79,360
| Closed | -$7.92M | – | 331 |
|
|
2020
Q1 | $7.92M | Sell |
79,360
-19,440
| -20% | -$1.94M | 0.43% | 61 |
|
|
2019
Q4 | $14.7M | Sell |
98,800
-52,700
| -35% | -$7.87M | 0.62% | 58 |
|
|
2019
Q3 | $19.4M | Sell |
151,500
-2,470
| -2% | -$317K | 0.68% | 59 |
|
|
2019
Q2 | $22M | Buy |
+153,970
| New | +$22M | 0.74% | 53 |
|
|
2014
Q2 | – | Sell |
-87,000
| Closed | -$12.1M | – | 432 |
|
|
2014
Q1 | $12.1M | Buy |
+87,000
| New | +$12.1M | 0.46% | 78 |
|
|
2013
Q4 | – | Sell |
-50,176
| Closed | -$4.62M | – | 413 |
|
|
2013
Q3 | $4.62M | Sell |
50,176
-12,876
| -20% | -$1.18M | 0.19% | 93 |
|
|
2013
Q2 | $4.33M | Buy |
+63,052
| New | +$4.33M | 0.19% | 105 |
|